Real-time cell analysis - A new method for dynamic, quantitative measurement of infectious viruses and antiserum neutralizing activity

Journal of Virological Methods

Volumn 193, Issue 2, 2013, Pages 364-370

  Teng, Zheng ^a   Kuang, Xiaozhou ^a   Wang, Jiayu ^a   Zhang, Xi ^a  

^a SHANGHAI MUNICIPAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

HEV71; RCTA; TCID50; Viral assay

Indexed keywords

VIRUS ANTIBODY;

ANALYZER; ANTIBODY TITER; ARTICLE; BIOSENSOR; CELL ADHESION; CELL ASSAY; CELL DAMAGE; CELL DEATH; CELL LINE; CELL PROLIFERATION; CELL VIABILITY; COMPUTER SYSTEM; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; ENTEROVIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERMETHOD COMPARISON; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME CELL ANALYSIS; RHABDOMYOSARCOMA; TISSUE CULTURE; VIRUS INFECTIVITY; VIRUS NEUTRALIZATION;

HEV71; RCTA; TCID(50); VIRAL ASSAY;

ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CELL LINE; CYTOLOGICAL TECHNIQUES; CYTOPATHOGENIC EFFECT, VIRAL; ENTEROVIRUS A, HUMAN; HUMANS; NEUTRALIZATION TESTS; VIRAL LOAD; VIROLOGY;

EID: 84881010914     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2013.06.034     Document Type: Article

References (37)

1. Atienza J.M., Yu N., Kirstein S.L., et al. Dynamic and label-free cell based assays using the real-time cell electronic sensing system. Assay Drug Dev. Technol. 2006, 4:597-607.
2. Barrett P.N., Mundt W., Kistner O., Howard M.K. Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines. Exp. Rev. Vaccines 2009, 8:607-618.
3. Barron A.L., Olshevsky C., Cohen M.M. Characteristics of the BGM line of cells from African green monkey kidney. Arch. Gesamte Virusforsch. 1970, 32:389-392.
4. Chua B.H., Phuektes P., Sanders S.A., Nicholls P.K., McMinn P.C. The molecular basis of mouse adaptation by human enterovirus 71. J. Gen. Virol. 2008, 89:1622-1632.
5. Fang Y., Ye P., Wang X., Reisen W. Real-time monitoring of flavivirus induced cytopathogenesis using cell electric impedance technology. J. Virol. Methods 2011, 173:251-258.
6. Fryer J.L., Lannan C.N. Three decades of fish cell culture: a current listing of cell lines derived from fishes. J. Tissue Culture Methods 1994, 16:87-94.
7. George M., Farooq M., Dang T., Cortes B., Liu J., Maranga L. Production of cell culture (MDCK) derived live attenuated influenza vaccine (LAIV) in a fully disposable platform process. Biotechnol. Bioeng. 2010, 106:906-917.
8. Ilarraza R., Wu Y., Davoine F., Ebeling C., Adamko D.J. Human dendritic cells promote an antiviral immune response when stimulated by CVT-E002. J. Pharm. Pharmacol. 2011, 63:670-678.
9. Ilyushina N.A., Ikizler M.R., Kawaoka Y., Rudenko L.G., Treanor J.J., Subbarao K., Wright P.F. Comparative study of influenza virus replication in MDCK cells and in primary cells derived from adenoids and airway epithelium. J. Virol. 2012, 86:11725-11734.
10. Irelan J.T., Wu M.J., Morgan J., Ke N., Wang X.B., Xu X., Abassi Y.A. Rapid and quantitative assessment of cell quality, identity, and functionality for cell-based assays using real-time cellular analysis. J. Biolmol. Screening 2011, 16:313-322.
11. Ke N., Wang X., Xu X., Abassi Y.A. The Xcelligence system for real-time and label-free monitoring of cell viability. Methods Mol. Biol. 2011, 740:33-43.
12. Lakra W.S., Swaminathan T.R., Joy K.P. Development characterization, conservation and storage of fish cell lines: a review. Fish Physiol. Biochem. 2011, 37:1-20.
13. Leland D.S., Ginocchio C.C. Role of cell culture for virus detection in the age of technology. Clin. Microbiol. Rev. 2007, 20:49-78.
14. Levy J.A. Virology 1994, 447. Prentice Hall, Englewood Cliffs, NJ. third ed.
15. Lifson J.D., Reyes G.R., McGrath M.S., Stein B.S., Engleman E.G. AIDS retrovirus induced cytopathology: giant cell formation and involvement of CD4 antigen. Science 1986, 232:1123-1127.
16. Liu J., Shi X., Schwartz R., Kemble G. Use of MDCK cells for production of live attenuated influenza vaccine. Vaccine 2009, 27:6460-6463.
17. Lohr V., Genzel Y., Jordan I., Katinger D., Mahr S., Sandig V., Reichl U. Live attenuated influenza viruses produced in a suspension process with avian AGE1.CR.pIX cells. BMC Biotechnol. 2012, 12:79.
18. lys-3 primer. J. Biol. Chem. 1997, 272(23):14523-14531.
19. Lu Y., Nerurkar V.R., Aguirre A.A., Work T.M., Balazs G.H., Yanagihara R. Establishment and characterization of 13 cell lines from a green sea turtle (Chelonia mydas) with fibropapillomas. In Vitro Cell Dev. Biol. 1999, 35(7):389-393.
20. Lu Y., Aguirre A.A., Hamm C., Wang Y., Yu Q., Loh P.C., Yanagihara R. Establishment, cryopreservation, and growth of 11 cell lines prepared from a juvenile Hawaiian monk seal, Monachus schauinslandi. Methods Cell Sci. 2001, 22:115-124.
21. Lu Y., Aguirre A.A., Wang Y., Loh P.C., Yanagihara R. Viral susceptibility of newly established cell lines from the Hawaiian monk seal. Dis. Aquat. Org. 2003, 57:183-191.
22. Menna J.H., Collin A.R., Flanagan T.D. Characterization of an in vitro persistent-state measles virus infection: species characterization and interference in the BGM/MV cell line. Infect. Immun. 1975, 11:159-163.
23. Monath T.P., Fowler E., Johnson C.T., Balser J., Morin M.J., Sisti M., Trent D.W. An inactivated cell-culture vaccine against yellow fever. N. Engl. J. Med. 2011, 364:1328-1333.
24. Moodley K., Angel C.E., Glass M., Graham E.S. Real-time profiling of NK cell killing of human astrocytes using Xcelligence technology. J. Neurosci. Methods 2011, 200:173-180.
25. Payment P., Trudel M. Methods and Techniques in Virology 1994, Marcel Dekker, Inc., New York.
26. Perdue M.L., Arnold F., Li S., Donabedian A., Cioce V., Warf T., Huebner R. The future of cell culture-based influenza vaccine production. Exp. Rev. Vaccines 2011, 10:1183-1194.
27. Rice C.M. New insights into HCV replication: potential antiviral targets. Top. Antiviral Med. 2011, 19:117-120.
28. Rougee L., Ostrander G.K., Richmond R.H., Lu Y. Establishment, characterization, and viral susceptibility of two cell lines derived from goldfish muscle and swim bladder Carassius auratus. Dis. Aquat. Org. 2007, 77:127-135.
29. Sainz B., Barretto N., Yu X., Corcoran P., Uprichard S.L. Permissiveness of human hepatoma cell lines for HCV infection. Virol. J. 2012, 24:0-30.
30. Shimizu N.S., Shimizu N.G., Takeuchi Y., Hoshino H. Isolation and characterization of human immunodeficiency virus type 1 variants infectious to brain-derived cells: detection of common point mutations in the V3 region of the env gene of the variants. J. Virol. 1994, 68:6130-6135.
31. Smith C.D., Craft D.W., Shiromoto R.S., Yan P.O. Alternative cell line for virus isolation. J. Clin. Microbiol. 1986, 24:265-268.
32. Solly K., Wang X.B., Xu X., Strulovici B., Zheng W. Application of real-time cell electronic sensing (RT-CES) technology to cell-based assays. ASSAY Drug Dev. Technol. 2004, 2(4):363-372.
33. Tong J., Trapido-Rosenthal H., Wang J., Wang Y.W., Li Q.X., Lu Y. Antiviral activities and putative identification of compounds in microbial extracts from the Hawaiian coastal waters. Mar. Drugs 2012, 10:521-538.
34. Wolf K., Mann J.A. Poikilotherm vertebrate cell lines and viruses: a current listing for fishes. In Vitro 1980, 16:168-179.
35. Wozniak M.A., Frost A.L., Preston C.M., Itzhaki R.F. Antivirals reduce the formation of key Alzheimer's disease molecules in cell cultures acutely infected with herpes simplex virus type 1. PLoS ONE 2011, 6:e25152.
36. Yasuhara-Bell J., Yang Y.B., Barlow R., Trapido-Rosenthal H., Lu Y. In vitro evaluation of marine-microorganism extracts for anti-viral activities. Virol. J. 2010, 10.1186/1743-422X-7-182.
37. Yian D., Zhang W., He J., Liu Y., Song Z., Zhou Z., Zheng M., Hu Y. Novel, real-time, cell analysis for measuring viral cytopathogenesis and the efficacy of neutralizing antibodies to the 2009 influenza A (H1N1) virus. PLoS ONE 2012, 7(2):e31965.